- Home
- TIL vs VSTM Comparison
TIL vs VSTM Comparison
Compare TIL & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- VSTM
- Stock Information
- Founded
- TIL 2018
- VSTM 2010
- Country
- TIL United States
- VSTM United States
- Employees
- TIL N/A
- VSTM N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- TIL Health Care
- VSTM Health Care
- Exchange
- TIL Nasdaq
- VSTM Nasdaq
- Market Cap
- TIL 230.1M
- VSTM 425.9M
- IPO Year
- TIL 2021
- VSTM 2012
- Fundamental
- Price
- TIL $23.81
- VSTM $4.85
- Analyst Decision
- TIL Buy
- VSTM Strong Buy
- Analyst Count
- TIL 5
- VSTM 9
- Target Price
- TIL $119.00
- VSTM $12.63
- AVG Volume (30 Days)
- TIL 334.3K
- VSTM 2.4M
- Earning Date
- TIL 08-12-2025
- VSTM 08-07-2025
- Dividend Yield
- TIL N/A
- VSTM N/A
- EPS Growth
- TIL N/A
- VSTM N/A
- EPS
- TIL N/A
- VSTM N/A
- Revenue
- TIL N/A
- VSTM $10,000,000.00
- Revenue This Year
- TIL N/A
- VSTM $129.06
- Revenue Next Year
- TIL N/A
- VSTM $306.32
- P/E Ratio
- TIL N/A
- VSTM N/A
- Revenue Growth
- TIL N/A
- VSTM N/A
- 52 Week Low
- TIL $9.62
- VSTM $2.10
- 52 Week High
- TIL $92.00
- VSTM $9.10
- Technical
- Relative Strength Index (RSI)
- TIL 45.83
- VSTM 40.44
- Support Level
- TIL $20.60
- VSTM $4.01
- Resistance Level
- TIL $31.67
- VSTM $6.62
- Average True Range (ATR)
- TIL 3.53
- VSTM 0.34
- MACD
- TIL -1.54
- VSTM -0.03
- Stochastic Oscillator
- TIL 17.93
- VSTM 42.00
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.